10h
GlobalData on MSNPharma industry dodges tariff blow but still braces for disruptionAccording to a factsheet published by the Trump administration, pharmaceuticals are exempted from the tariffs – for now.
Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the ...
Drugmaker stocks gained a temporary reprieve on Thursday as U.S. President Donald Trump spared pharmaceutical products from ...
Analysts said tariffs would send prescription drug prices higher. Generic drugs and ingredients that are largely made ...
US President Trump has exempted Indian pharmaceuticals from new reciprocal tariffs, benefiting India's pharmaceutical sector.
Trump announced a 10% tariff on all U.S. trading partners, in addition to higher reciprocal tariffs on the EU and China. But ...
Hosted on MSN6d
Trump targets Irish pharmaceutical industry for US tariffsUS President Donald Trump has again singled out Ireland's pharmaceutical industry as a target for tariffs. Trump was speaking ...
In recent years, the pharmaceutical landscape has witnessed a seismic shift as cannabinoids transition from niche alternatives to mainstream medical solutions.
As long as pharmaceutical tariffs are being considered, their potential threat to the pharmaceutical industry and the people ...
US President says India imposes 52% tariff on American imports and engages in currency manipulation and non-tariff barriers ...
Europe’s pharmaceutical sector is bracing for the potential impact of U.S. tariffs as hopes of an industry-wide exemption by ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results